AI summary by TwinMind

How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill

Andrew Huberman

3h 52m 38s

Introduction and Cannabis Basics

  • Dr. Matthew Hill: Professor of Cell Biology and Anatomy at University of Calgary
  • Studies cannabis effects on stress, feeding, and behavioral impacts across development
  • Cannabis contains 70+ cannabinoids, THC is primary psychoactive compound
  • CBD is second major component but non-intoxicating
  • Terpenes contribute to smell/flavor, may influence effects but unclear
  • "Entourage effect" theory suggests combined molecules work differently than isolated THC

Endocannabinoid System Biology

  • CB1 receptors most widely expressed in brain (except brainstem cardiorespiratory areas)
  • CB2 receptors mainly on immune cells, regulate inflammation
  • Endocannabinoids work retrograde (backwards) across synapses
  • Two main endocannabinoids:
    • Anandamide: high affinity, low efficacy, "tonic" regulator
    • 2-AG: lower affinity, high efficacy, "phasic" on-demand molecule
  • Primary role: maintain homeostasis, prevent runaway excitation/inhibition
  • Dopamine neurons uniquely lack CB1 receptors

THC vs Endocannabinoids

  • THC acts as partial agonist at CB1, high affinity but lower efficacy than 2-AG
  • Key difference: THC "carpet bombs" all CB1 receptors simultaneously
  • Endocannabinoids released spatially/temporally specific
  • Elevating anandamide via enzyme inhibition produces no psychoactive effects
  • THC intoxication likely due to widespread simultaneous network disruption

Routes of Administration and Dosing

  • Smoking/vaping: 2-5 minute onset, peak 15-30 minutes, duration 2-4 hours
  • Blood levels ~100 nanograms/mL regardless of cannabis potency (self-titration)
  • Edibles: 30-90 minute onset, 4-8 hour duration, lower blood levels (2-5 ng/mL)
  • Edibles produce 11-hydroxy-THC metabolite, more potent than THC
  • Concentrates (dabs) can't be titrated, produce 200-300 ng/mL blood levels

Cannabis Potency and Tolerance

  • 1970s cannabis: ~5% THC; modern: 20-30% THC
  • People self-regulate to achieve similar blood levels across potencies
  • Plant biology limits natural THC to ~25-30% maximum
  • Concentrates (90-98% THC) are problematic - can't be titrated
  • Tolerance more prominent with high-potency extracts
  • Most users don't escalate like other drugs

Cannabis Use Disorder and Addiction

  • ~30% of weekly users may develop cannabis use disorder
  • Criteria similar to other substance use disorders
  • Can consume time/energy, risky behavior for access, relationship/responsibility impacts
  • Withdrawal symptoms: irritability when access unavailable

Legalization Effects

  • Biggest use increases in elderly populations (especially women 55+)
  • Young adult (20-24) use increased
  • Teenage use rates remained stable or slightly decreased
  • ER visits increased due to:
    • Unintentional pediatric edible consumption
    • Policy changes making people more likely to seek help

Sativa vs Indica Strains

  • Botanical terms referring to plant shape, not chemical composition
  • No consistent chemical differences between sativa/indica classifications
  • Variability within each category greater than between categories
  • Subjective effects likely due to expectancy bias
  • No blinded clinical trials demonstrating differential effects

CBD (Cannabidiol)

  • Doesn't bind CB1 receptors, no psychoactive effects
  • Most street cannabis contains <1% CBD (bred out in favor of THC)
  • Clinical efficacy only demonstrated in pediatric epilepsy at very high doses (1500-2000mg)
  • Commercial CBD products (2-25mg) likely produce placebo effects
  • Poor bioavailability (~4% oral), improved with fatty meals (~20%)
  • May work through adenosine transporter inhibition (anti-caffeine effect)
  • High doses can saturate liver enzymes, affecting other drug metabolism

THC and Psychosis/Schizophrenia

  • Acute cannabis-induced psychotic episodes possible but rare
  • Association between cannabis use and schizophrenia development exists
  • Correlation vs causation debate:
    • Cannabis users have higher schizophrenia rates
    • People with schizophrenia use cannabis at higher rates
  • Alternative explanation: genetic predisposition to both conditions
  • Genetic studies suggest schizophrenia risk predicts cannabis use more than reverse
  • Schizophrenia rates stable despite increased cannabis use since 1960s
  • Countries with low cannabis use have similar schizophrenia rates
  • Cannabis may accelerate onset in predisposed individuals rather than cause denovo

Bipolar and Mental Health

  • Similar hereditary patterns between schizophrenia and bipolar
  • Limited research on cannabis-bipolar interactions
  • Recommendation: avoid cannabis if family history of schizophrenia or bipolar

Cannabis and Anxiety

  • Biphasic effects: low doses reduce anxiety, high doses increase anxiety
  • 85% of users report using cannabis to reduce stress/anxiety
  • Mechanism involves differential effects on excitatory vs inhibitory neurons
  • Low doses affect glutamate neurons (anti-anxiety)
  • High doses affect GABA neurons (pro-anxiety)
  • May help people with naturally low anandamide levels

Medical Applications

  • Pain: Most evidence-supported use, strips away emotional component rather than direct analgesia
  • Appetite: Effective for cancer patients, tricks brain into "fasting" state
  • PTSD: Small studies show nightmare suppression, improves sleep quality
  • Glaucoma: Can reduce eye pressure
  • Pediatric Epilepsy: CBD highly effective for specific conditions like Dravet syndrome

Health Risks and Harms

  • Cardiovascular: Vasodilation causes postural hypotension, compensatory tachycardia
    • Potential increased stroke/cardiac event risk in vulnerable populations
  • Respiratory: Lung damage from combustion, but lower cancer risk than cigarettes
  • Cyclic Vomiting Syndrome: Rare condition in heavy users, treated with hot showers
  • Drug Testing: THC stored in fat, detectable 30+ days, exercise can cause re-release
  • Driving Impairment: No reliable roadside testing due to complex pharmacokinetics

Hormonal Effects

  • Mixed evidence on testosterone/estrogen effects
  • Transient testosterone drops reported but within normal ranges
  • Prolactin generally suppressed (opposite of some claims)
  • Potential sperm quality effects in some individuals
  • Pregnancy use: 2-15% prevalence, mostly first trimester before awareness

Memory and Cognitive Effects

  • Acute short-term memory impairment during intoxication
  • State-dependent learning can develop with regular use
  • No compelling evidence for long-term permanent cognitive effects
  • Tolerance develops to cognitive impairments

Cannabis and Sleep

  • THC helps sleep initiation but alters REM architecture
  • REM suppression may be beneficial for PTSD (reduces nightmares)
  • Not recommended as general sleep aid due to architecture changes

Future Research Directions

  • Need for blinded studies on strain differences
  • Entourage effect research with isolated terpenes/cannabinoids
  • Better understanding of individual variation in responses
  • Genetic factors predicting benefits vs risks

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome